Study guide

15.2 Oncologic Emergencies, Acute Kidney Injury & Pediatric Electrolyte Crises

Neonatal Pediatric Transport C-NPT

Track your progress as you read

Finished sections get a check mark.

1 Introduction: The C-NPT Exam

About the C-NPT Exam: 2026 Format, Eligibility & Content Outline

2 Chapter 1: Transport Systems, Regulatory Framework & Legal Issues

1.1 Transport System Architecture, Accreditation (CAMTS) & Dispatch Triage 1.2 Regulatory & Legal Mandates: EMTALA, HIPAA, Consent & Documentation 1.3 Medical Direction, Scope of Practice & Ethical Considerations

3 Chapter 2: Safety, Communication, Crew Resource Management & Transport Environment

2.1 Crew Resource Management (CRM), Situational Awareness & Sterile Cockpit 2.2 Aircraft & Ground Ambulance Operations, Landing Zones & Vehicle Dynamics 2.3 Environmental Hazards, Weather Minimums & In-Flight Emergency Procedures 2.4 Communication in Transport: Peer Handoffs, Age-Appropriate Care, Families & Crew Stressors 2.5 Infection Control, PPE, Scene Safety & Disaster/Evacuation Planning

4 Chapter 3: Flight Physiology & Environmental Stressors

3.1 Physical Gas Laws & Transport Implications (Boyle, Dalton, Charles, Henry, Graham) 3.2 Altitude Hypoxia, Barometric Pressure Changes & Dysbarism 3.3 Acceleration Forces (G-forces), Vibration & Acoustic Stress in Transit 3.4 Thermoregulation Physics & Neutral Thermal Environment in Transit

5 Chapter 4: Invasive Procedures & Transport Monitoring

4.1 Advanced Airway Management & Endotracheal Intubation in Transit 4.2 Pleural Decompression (Needle Thoracostomy & Chest Tube Management) 4.3 Vascular Access: Umbilical Lines (UAC/UVC), Intraosseous (IO) & Arterial Lines

6 Chapter 5: Transport Equipment, Respiratory Physiology & Mechanical Ventilation

5.1 Transport Incubators (Isolettes), Thermal Control & Electrical/Gas Power Systems 5.2 Portable Ventilators & Modes (PC, VC, PRVC, High Frequency) 5.3 Gas Cylinder Duration Calculations, Oxygen Delivery & Inhaled Nitric Oxide (iNO) 5.4 Respiratory Physiology: Acid-Base Balance, Oxygenation, Lung Mechanics & Troubleshooting

7 Chapter 6: Transport Pharmacology, Resuscitation, Fluids & Electrolytes

6.1 Vasoactive Infusions & Inotropes (Epinephrine, Dopamine, Dobutamine, Milrinone) 6.2 Sedation, Analgesia & Neuromuscular Blockade in Transport 6.3 Prostaglandin E1 (Alprostadil) & Surfactant Replacement Therapy 6.4 Resuscitation Protocols (NRP, PALS) & Shock Fluid Resuscitation 6.5 Antimicrobial Pharmacology in Neonatal & Pediatric Transport 6.6 Post-Resuscitation Care, Defibrillation & Cardioversion in Transit, ECMO Indications & the Transport-vs-Stay Decision 6.7 Fluid & Electrolyte Therapy Across the Ages: Maintenance, Dehydration, Fluid Overload & Electrolyte Emergencies

8 Chapter 7: Neonatal Respiratory Pathologies & Management

7.1 Respiratory Distress Syndrome (RDS) & Surfactant Deficiency 7.2 Meconium Aspiration Syndrome (MAS) & Persistent Pulmonary Hypertension (PPHN) 7.3 Transient Tachypnea (TTN), Neonatal Pneumothorax & Congenital Diaphragmatic Hernia (CDH) 7.4 Neonatal Upper Airway Anomalies, Aspiration, Pneumonia, Chronic Lung Disease & Respiratory Failure

9 Chapter 8: Neonatal Cardiovascular Critical Care

8.1 Ductal-Dependent Cyanotic Congenital Heart Defects (TGA, TOF, Tricuspid Atresia) 8.2 Ductal-Dependent Systemic Blood Flow Lesions (HLHS, Coarctation, Interrupted Arch) 8.3 Neonatal Arrhythmias, Cardiogenic Shock & Post-Resuscitation Care 8.4 Acyanotic Congenital Heart Lesions, Patent Ductus Arteriosus, Obstructed TAPVR & Neonatal Heart Failure

10 Chapter 9: Neonatal Neurological & Metabolic Crises

9.1 Hypoxic-Ischemic Encephalopathy (HIE) & Passive/Active Therapeutic Hypothermia 9.2 Neonatal Seizures & Intraventricular Hemorrhage (IVH) 9.3 Neonatal Hypoglycemia, Electrolyte Derangements & Hyperbilirubinemia 9.4 Subgaleal Hemorrhage, Neonatal Sepsis & Meningitis, and Perinatal Substance Exposure (NOWS)

11 Chapter 10: Neonatal Surgical Emergencies, Neural Tube Defects & ELBW Care

10.1 Abdominal Wall Defects (Gastroschisis vs. Omphalocele) & TEF/Esophageal Atresia 10.2 Necrotizing Enterocolitis (NEC), Malrotation with Volvulus & Intestinal Obstruction 10.3 Care of the Extremely Low Birth Weight (ELBW) Infant (<1000g) in Transit 10.4 Neural Tube Defects: Myelomeningocele, Encephalocele & Transport of the Newborn With an Open Spinal Defect

12 Chapter 11: Pediatric Respiratory Emergencies

11.1 Acute Upper Airway Obstruction (Croup, Epiglottitis, Bacterial Tracheitis, Foreign Body) 11.2 Lower Airway Crises: Status Asthmaticus & Severe Bronchiolitis 11.3 Pediatric Acute Respiratory Distress Syndrome (PARDS) & Severe Pneumonia

13 Chapter 12: Pediatric Shock & Cardiovascular Crises

12.1 Pathophysiology & Transport Management of Pediatric Septic Shock 12.2 Hypovolemic, Cardiogenic & Anaphylactic Shock in Children 12.3 Pediatric Cardiac Emergencies: SVT, Ventricular Arrhythmias & Myocarditis 12.4 Pediatric Cardiovascular Crises: Palliated Congenital Heart Disease, Pulmonary Hypertensive Crisis, Pericarditis & Tamponade, Hypertensive Emergency & Anterior Mediastinal Mass

14 Chapter 13: Pediatric Neurological Emergencies & Trauma

13.1 Status Epilepticus, Altered Mental Status & Meningitis/Encephalitis 13.2 Pediatric Traumatic Brain Injury (TBI) & Increased Intracranial Pressure (ICP) 13.3 Blunt/Penetrating Trauma, Spinal Motion Restriction & Thermal Burns 13.4 Non-Accidental Trauma, Smoke Inhalation (Carbon Monoxide & Cyanide) & Heat Illness

15 Chapter 14: Pediatric Toxicological, Environmental & Endocrine Emergencies

14.1 Common Pediatric Toxic Ingestions, Poisonings & Antidotes 14.2 Diabetic Ketoacidosis (DKA) & Environmental Emergencies (Submersion, Hypothermia) 14.3 Button Battery & Foreign-Body Ingestions, Bites & Envenomations, and Hazardous-Material Exposures

16 Chapter 15: Pediatric Metabolic & Hematologic Emergencies

15.1 Anemia, Sickle Cell Disease, Coagulopathies & Blood Product Administration 15.2 Oncologic Emergencies, Acute Kidney Injury & Pediatric Electrolyte Crises

15.2 Oncologic Emergencies, Acute Kidney Injury & Pediatric Electrolyte Crises

Key Takeaways Explain This Topic AI

Tumor lysis syndrome (hyperkalemia, hyperphosphatemia, hyperuricemia, secondary hypocalcemia, and kidney injury) is prevented and treated with vigorous hydration (commonly about 2–3 L/m²/day), no added potassium, and uric acid-lowering therapy.

Rasburicase lowers uric acid rapidly but is contraindicated in G6PD deficiency because it can cause hemolysis and methemoglobinemia.

Fever with an absolute neutrophil count below 500/mcL is an emergency that requires blood cultures and an antipseudomonal beta-lactam (for example, cefepime) as soon as possible, usually within 60 minutes.

Hyperleukocytosis (white blood cell count above about 100,000/mcL) causes leukostasis, so unnecessary red cell transfusion that raises blood viscosity is avoided until the white count is reduced.

Acute kidney injury is classified by rising creatinine or falling urine output; hemolytic uremic syndrome (hemolytic anemia, thrombocytopenia, and AKI, often after bloody diarrhea from Shiga toxin-producing E. coli) is a leading pediatric cause.

Last updated: September 2026

Oncologic Emergencies, Acute Kidney Injury & Electrolyte Crises

Children with cancer and children with kidney failure are transported at their most unstable moments: at diagnosis, during early chemotherapy, and during complications. Many of these emergencies are metabolic, and they interact with one another. For example, tumor lysis causes kidney injury, which worsens hyperkalemia.

Tumor Lysis Syndrome (TLS)

TLS occurs when rapidly dividing tumor cells break down, spontaneously or after treatment starts. It is most common in Burkitt lymphoma, T-cell lymphoblastic lymphoma, and leukemias with high white counts .

  • Laboratory finding Mechanism Danger
  • Hyperkalemia Intracellular potassium release Arrhythmias and cardiac arrest
  • Hyperphosphatemia Phosphate release from tumor cells Precipitates with calcium, causing kidney injury
  • Hypocalcemia (secondary) Calcium binds phosphate Tetany, seizures, arrhythmias
  • Hyperuricemia Nucleic acid breakdown to uric acid Uric acid crystals injure the kidneys
  • Acute kidney injury Crystal deposition, dehydration Worsens every abnormality above

Prevention and treatment:

Hydration: Commonly about 2–3 L/m²/day (roughly twice maintenance) to keep urine output high. Give no potassium in the fluids.

Uric acid control:

Allopurinol prevents new uric acid formation.

Rasburicase breaks down existing uric acid rapidly. It is contraindicated in G6PD deficiency because it can cause hemolysis and methemoglobinemia.

Urine alkalinization is no longer routine. It can promote calcium phosphate precipitation.

Treat hyperkalemia as in Section 6.7. Treat symptomatic hypocalcemia cautiously, because giving calcium when phosphate is very high can cause calcium phosphate precipitation.

Monitor electrolytes frequently, and involve nephrology early. Dialysis may be needed.

During transport, have ECG monitoring, calcium, insulin and dextrose, and a plan for arrhythmia.

Febrile Neutropenia

Definition: Fever in a child with an absolute neutrophil count (ANC) below 500/mcL (or expected to fall below that level). It is common after chemotherapy.

Why it is an emergency: Neutropenic children can have little inflammatory response, so sepsis may progress to shock quickly with few localizing signs.

Management:

Blood cultures from the central line (and peripherally per protocol)

An antipseudomonal beta-lactam (for example, cefepime or piperacillin-tazobactam) as soon as possible, usually within 60 minutes

  • Vancomycin is added for suspected catheter infection, skin or soft-tissue infection, pneumonia, or instability
  • Treat shock (Section 12.1)

Avoid rectal temperatures and rectal medications because of mucosal injury and infection risk.

Typhlitis (neutropenic enterocolitis) causes right lower quadrant pain, distension, and diarrhea and can perforate. Keep the child NPO, provide anaerobic coverage, and obtain surgical evaluation.

Hyperleukocytosis and Leukostasis

Hyperleukocytosis: White count above about 100,000/mcL , most often in acute leukemia.

Leukostasis: Sludging of leukemic blasts in small vessels, especially in the lungs and brain. It causes hypoxemia, respiratory distress, headache, confusion, stroke, and intracranial hemorrhage.

Management:

  • Hydration
  • Tumor lysis precautions
  • Correct coagulopathy and thrombocytopenia (platelets carry little risk of raising viscosity)

Avoid unnecessary red cell transfusion , which raises blood viscosity. Transfuse cautiously only for clear indications.

  • Cytoreduction by oncology (chemotherapy, sometimes leukapheresis)
  • Other Oncologic Emergencies

Anterior mediastinal mass and superior vena cava syndrome: Airway and anesthesia risks (Section 12.4).

Spinal cord compression: Back pain, weakness, sensory level, bladder or bowel dysfunction. Give corticosteroids per oncology or neurosurgery, obtain urgent MRI, and preserve neurological function.

Increased intracranial pressure from brain tumors: Section 13.2 principles apply, and ventriculoperitoneal shunts may be present.

Hypercalcemia of malignancy (less common in children): Hydration, then calcium-lowering therapy per oncology.

Acute Kidney Injury (AKI)

AKI is staged by rising serum creatinine (for example, 1.5 times baseline or more) and/or reduced urine output (for example, below 0.5 mL/kg/h for 6 hours or more) under the KDIGO framework, with pediatric adaptations.

Category Pediatric examples Clues

Prerenal Dehydration, shock, heart failure, hepatorenal physiology Responds to restoring perfusion; concentrated urine

Intrinsic renal Acute tubular necrosis (after shock), hemolytic uremic syndrome , glomerulonephritis, nephrotoxins (aminoglycosides, NSAIDs, contrast, vancomycin), rhabdomyolysis, tumor lysis Casts, hematuria, proteinuria, history

Postrenal Posterior urethral valves in boys, neurogenic bladder (Section 10.4), obstructed catheter Distended bladder, hydronephrosis

Hemolytic uremic syndrome (HUS)

The classic triad is microangiopathic hemolytic anemia (schistocytes), thrombocytopenia , and AKI .

It usually follows bloody diarrhea from Shiga toxin-producing E. coli (such as O157:H7), typically within days to about 2 weeks.

Complications include hypertension, seizures, stroke, pancreatitis, and heart involvement.

Management: Supportive care with careful fluids, dialysis when needed, and transfusion for severe anemia. Platelet transfusion is avoided unless bleeding or a procedure requires it. Antimotility agents are avoided in bloody diarrhea, and antibiotics are generally avoided in suspected STEC infection because of concern that they may increase toxin release.

AKI management in transport

Restore perfusion. Then avoid fluid overload : track intake and output and calculate percent fluid overload (Section 6.7).

Stop or adjust nephrotoxic drugs and renally cleared drug doses.

Treat hyperkalemia, acidosis, hyponatremia, hypocalcemia, and hypertension (Section 12.4).

Indications for urgent dialysis or renal replacement therapy include refractory hyperkalemia, severe acidosis, fluid overload with respiratory compromise, uremic complications (encephalopathy, pericarditis, bleeding), and some toxic ingestions. These indications may determine which center the child needs.

Pediatric Electrolyte and Endocrine Crises

Section 6.7 covers sodium, potassium, calcium, and magnesium disorders. Two endocrine emergencies commonly present to transport teams:

Adrenal crisis: Children with congenital adrenal hyperplasia (salt-wasting forms present in the first weeks with vomiting, dehydration, hyponatremia, hyperkalemia, and hypoglycemia ), adrenal insufficiency, or chronic steroid use who become ill.

Give stress-dose hydrocortisone (commonly about 50–100 mg/m², or a weight-based dose per protocol) promptly.

Give isotonic fluid and dextrose.

Treat hyperkalemia.

Do not wait for cortisol levels in an unstable child.

Diabetic ketoacidosis is covered in Section 14.2. Remember potassium shifts and cerebral edema.

Transport Scenario

A 9-year-old with newly diagnosed Burkitt lymphoma and a large abdominal mass has potassium 6.4 mEq/L, phosphate 9.8 mg/dL, calcium 7.1 mg/dL, uric acid 14 mg/dL, and falling urine output. Before transport, the team:

  • Starts potassium-free hydration at about 3 L/m²/day
  • Gives calcium gluconate for peaked T waves after discussion with medical control
  • Starts insulin and dextrose to shift potassium
  • Confirms that G6PD testing was sent before rasburicase is considered

The receiving oncology and nephrology teams are told that urgent dialysis may be needed.